See every side of every news story
Published loading...Updated

Guadalupe Sabio, the scientist who pursues the 'ozempic' of liver cancer: "We seek microproteins to use them as therapy"

Summary by 20minutos
The incidence of liver cancer in Spain is 6,856 cases per year. Of these, 5,334 in men and 1,522 in women. Not being one of the most prevalent tumors, the fifth being the most annual deaths caused by one of the worst lethalities. "95 per cent of the population suffering from it dies in less than three months," explains Guadalupe Sabio, a biochemist who researches from his laboratory at the National Cancer Research Center (CNIO) the relationship …

2 Articles

All
Left
Center
1
Right
Center

The incidence of liver cancer in Spain is 6,856 cases per year. Of these, 5,334 in men and 1,522 in women. Not being one of the most prevalent tumors, the fifth being the most annual deaths caused by one of the worst lethalities. "95 per cent of the population suffering from it dies in less than three months," explains Guadalupe Sabio, a biochemist who researches from his laboratory at the National Cancer Research Center (CNIO) the relationship …

·Madrid, Spain
Read Full Article

Guadalupe Sabio, head of the Inter-Organ Interaction Group on Metabolic Diseases of the National Center for Oncological Research (CNIO), received yesterday the CRIS Excellence Program Award 2025-2030. The award, awarded by the CRIS Foundation against Cancer, is awarded with 1,250,000 euros, which will go to the CRIS Liver Cancer Project, led by Sabio to study how obesity affects the development of liver cancer. This type of cancer is one of the …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

20minutos broke the news in Madrid, Spain on Friday, April 11, 2025.
Sources are mostly out of (0)